Patents by Inventor Corey J. Bloom

Corey J. Bloom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9757464
    Abstract: Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: September 12, 2017
    Assignee: Bend Research, Inc.
    Inventors: Warren K. Miller, David T. Vodak, Daniel E. Dobry, David K. Lyon, Dwayne T. Friesen, Michael M. Morgen, Corey J. Bloom, Daniel T. Smithey
  • Publication number: 20160287568
    Abstract: The invention encompasses a composition comprising the reverse transcriptase (“RT”) inhibitor 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile sufficiently mixed in a concentration enhancing polymer, and processes for making the same. The composition and processes of the present invention significantly improve the bioavailability of the aforementioned RT inhibitor, while maintaining physical stability.
    Type: Application
    Filed: November 19, 2014
    Publication date: October 6, 2016
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Michael Lowinger, Aditya S. Tatavarti, Patrick Jules Marsac, Kristin J.M. Ploeger, John M. Baumann, Corey J. Bloom, Katherine Anne Brookhart
  • Patent number: 9233078
    Abstract: A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an amine-functionalized methacrylate copolymer.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: January 12, 2016
    Assignee: Bend Research, Inc.
    Inventors: Corey J. Bloom, Marshall David Crew, Warren Kenyon Miller
  • Patent number: 9060938
    Abstract: Solid dry powder compositions comprising active agents and dextran polymer derivatives comprising an ester-linked amine-containing substituent and an alkyl ester substituent are disclosed, as are methods for making such compositions.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: June 23, 2015
    Assignee: Bend Research, Inc.
    Inventors: Warren K. Miller, Michael M. Morgen, Corey J. Bloom
  • Publication number: 20140161895
    Abstract: Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.
    Type: Application
    Filed: February 12, 2014
    Publication date: June 12, 2014
    Applicant: Bend Research, Inc.
    Inventors: Warren K. Miller, David T. Vodak, Daniel E. Dobry, David K. Lyon, Dwayne T. Friesen, Michael M. Morgen, Corey J. Bloom, Daniel T. Smithey
  • Patent number: 8735570
    Abstract: Cationic dextran polymer derivatives including an ester-linked amine-containing substituent and an alkyl ester substituent and methods for making such dextran polymer derivatives are disclosed.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: May 27, 2014
    Assignee: Bend Research, Inc.
    Inventors: Warren K. Miller, Michael M. Morgen, Corey J. Bloom
  • Patent number: 8685458
    Abstract: Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: April 1, 2014
    Assignee: Bend Research, Inc.
    Inventors: Warren K. Miller, David T. Vodak, Daniel E. Dobry, David K. Lyon, Dwayne T. Friesen, Michael M. Morgen, Corey J. Bloom, Daniel T. Smithey
  • Publication number: 20120288491
    Abstract: Solid dry powder compositions comprising active agents and dextran polymer derivatives comprising an ester-linked amine-containing substituent and an alkyl ester substituent are disclosed, as are methods for making such compositions.
    Type: Application
    Filed: May 10, 2012
    Publication date: November 15, 2012
    Inventors: Warren K. Miller, Michael M. Morgen, Corey J. Bloom
  • Publication number: 20120283427
    Abstract: Cationic dextran polymer derivatives including an ester-linked amine-containing substituent and an alkyl ester substituent and methods for making such dextran polymer derivatives are disclosed.
    Type: Application
    Filed: May 14, 2012
    Publication date: November 8, 2012
    Inventors: Warren K. Miller, Michael M. Morgen, Corey J. Bloom
  • Publication number: 20120003282
    Abstract: Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.
    Type: Application
    Filed: March 3, 2010
    Publication date: January 5, 2012
    Inventors: Warren K. Miller, David T. Vodak, Daniel E. Dobry, David K. Lyon, Dwayne T. Friesen, Michael M. Morgen, Corey J. Bloom, Daniel t. Smithey
  • Publication number: 20100297237
    Abstract: A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an amine-functionalized methacrylate copolymer.
    Type: Application
    Filed: December 5, 2008
    Publication date: November 25, 2010
    Applicant: Bend Research, Inc.
    Inventors: Corey J. Bloom, Marshall David Crew, Warren Kenyon Miller
  • Patent number: 7414359
    Abstract: The present invention provides conductive metal-ligand coordination complexes that are useful in a variety of electronic devices. For example, such complexes are useful in organic light emitting devices composed of one or more layers of organic material between two conductors. The use of metal-ligand coordination complexes of the present invention as the cathode, replaces the more typically employed reactive metals, which function as the electron injecting contact, and provides for improved or longer-lived devices.
    Type: Grant
    Filed: August 12, 2003
    Date of Patent: August 19, 2008
    Assignee: Colorado State University Research Foundation
    Inventors: C. Michael Elliott, Corey J. Bloom